Trials / Completed
CompletedNCT02804490
Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 255 (actual)
- Sponsor
- Johns Hopkins Bloomberg School of Public Health · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this randomized control trial is to test the impact of provitamin A carotenoid biofortified maize meal consumption on maternal and infant vitamin A status.
Detailed description
Vitamin A deficiency remains a major public health problem in low and middle income countries. Approximately 50% of Zambian children are thought to be affected. This randomized control trial will test the efficacy of provitamin A carotenoid biofortified maize meal consumption as a strategy to improve vitamin A status among lactating Zambian mothers and their infants. The investigators will enroll up to 255 mother/infant pairs to a three-month study, during which they will receive one of the following three interventions: 1) conventional white maize, 2) provitamin A carotenoid biofortified orange maize, or 3) preformed vitamin A fortified white maize.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Conventional white maize | Women and their infants will receive 2 meals/day prepared with conventional white maize flour (287 g dry weight/d for women; 50 g dry weight/d for infants), 6 days/week for 15 weeks |
| DIETARY_SUPPLEMENT | Provitamin A carotenoid biofortified maize | Women and their infants will receive 2 meals/day prepared with provitamin A carotenoid biofortified orange maize flour (287 g dry weight/d for women; 50 g dry weight/d for infants), 6 days/week for 15 weeks |
| DIETARY_SUPPLEMENT | Preformed vitamin A fortified maize | Women and their infants will receive 2 meals/day prepared with preformed vitamin A fortified, conventional white maize flour (287 g dry weight/d for women; 50 g dry weight/d for infants), 6 days/week for 15 weeks |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-06-02
- Completion
- 2017-06-02
- First posted
- 2016-06-17
- Last updated
- 2017-08-21
Locations
1 site across 1 country: Zambia
Source: ClinicalTrials.gov record NCT02804490. Inclusion in this directory is not an endorsement.